EA200400311A1 - Кристаллы производных гидроксинорэфедрина - Google Patents
Кристаллы производных гидроксинорэфедринаInfo
- Publication number
- EA200400311A1 EA200400311A1 EA200400311A EA200400311A EA200400311A1 EA 200400311 A1 EA200400311 A1 EA 200400311A1 EA 200400311 A EA200400311 A EA 200400311A EA 200400311 A EA200400311 A EA 200400311A EA 200400311 A1 EA200400311 A1 EA 200400311A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- ethyl
- hydroxynorephedrine
- crystals
- derivatives
- pollakiuria
- Prior art date
Links
- WXFIGDLSSYIKKV-RCOVLWMOSA-N L-Metaraminol Chemical class C[C@H](N)[C@H](O)C1=CC=CC(O)=C1 WXFIGDLSSYIKKV-RCOVLWMOSA-N 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 206010036018 Pollakiuria Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 102000015005 beta-adrenergic receptor activity proteins Human genes 0.000 abstract 1
- 108040006818 beta-adrenergic receptor activity proteins Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Настоящее изобретение касается гидрохлорида этил (-)-2-[4-[2-[[(1S,2R)-2-гидрокси-2-(4-гидроксифенил)-1-метилэтил]амино]этил]-2,5-диметилфенокси]ацетата, его кристаллических форм и содержащих их фармацевтических композиций, которые обладают превосходными эффектами стимуляции β-адреноцепторов, терапевтическим действием в отношении поллакиурии или недержания мочи и стабильностью при хранении и полезны в качестве лекарственного средства.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001277345 | 2001-09-13 | ||
PCT/JP2002/008596 WO2003024916A1 (fr) | 2001-09-13 | 2002-08-27 | Cristaux d'un derive d'hydroxynorephedrine |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200400311A1 true EA200400311A1 (ru) | 2004-08-26 |
EA006022B1 EA006022B1 (ru) | 2005-08-25 |
Family
ID=19101883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200400311A EA006022B1 (ru) | 2001-09-13 | 2002-08-27 | Кристаллы производных гидроксинорэфедрина |
Country Status (29)
Country | Link |
---|---|
US (1) | US7208520B2 (ru) |
EP (1) | EP1426355B1 (ru) |
JP (1) | JP4157036B2 (ru) |
KR (2) | KR100874952B1 (ru) |
CN (1) | CN1275936C (ru) |
AT (1) | ATE411276T1 (ru) |
AU (1) | AU2002330453B2 (ru) |
BR (1) | BR0212494A (ru) |
CA (1) | CA2458544C (ru) |
CO (1) | CO5560555A2 (ru) |
CY (1) | CY1109409T1 (ru) |
DE (1) | DE60229404D1 (ru) |
DK (1) | DK1426355T3 (ru) |
EA (1) | EA006022B1 (ru) |
EC (1) | ECSP045017A (ru) |
ES (1) | ES2314092T3 (ru) |
HK (1) | HK1070051A1 (ru) |
HR (1) | HRP20040250A2 (ru) |
HU (1) | HUP0401694A3 (ru) |
IL (2) | IL160681A0 (ru) |
MX (1) | MXPA04002449A (ru) |
NO (1) | NO328252B1 (ru) |
NZ (1) | NZ531602A (ru) |
PL (1) | PL206246B1 (ru) |
PT (1) | PT1426355E (ru) |
SI (1) | SI1426355T1 (ru) |
UA (1) | UA77000C2 (ru) |
WO (1) | WO2003024916A1 (ru) |
ZA (1) | ZA200401757B (ru) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
JP4602969B2 (ja) * | 2003-05-05 | 2010-12-22 | キッセイ薬品工業株式会社 | 過活動膀胱を治療するためのフェノキシ酢酸誘導体の使用 |
DE10351271A1 (de) * | 2003-10-31 | 2005-06-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Zusammensetzung zur Behandlung der Stressinkontinenz und/oder Mischinkontinenz |
JP2007509896A (ja) * | 2003-11-03 | 2007-04-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | β−3−アドレノセプターアゴニスト及びαアンタゴニスト及び/又は5−αレダクターゼインヒビターを含有する医薬組成物 |
DE10352132A1 (de) * | 2003-11-04 | 2005-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten |
WO2005092321A1 (ja) * | 2004-03-24 | 2005-10-06 | Kissei Pharmaceutical Co., Ltd. | 頻尿または尿失禁の予防または治療用医薬組成物 |
JP4808613B2 (ja) * | 2004-03-24 | 2011-11-02 | キッセイ薬品工業株式会社 | 頻尿または尿失禁の予防または治療用医薬 |
EP1612203B1 (en) * | 2004-06-28 | 2007-08-01 | Grünenthal GmbH | Crystalline forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride |
DE102004050952A1 (de) * | 2004-10-18 | 2006-04-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Zusammensetzung zur Behandlung von Beschwerden, die mit krankhaften Veränderungen oder Irritationen der Prostata verbunden sind |
CA2580170A1 (en) * | 2004-10-18 | 2006-04-27 | Boehringer Ingelheim International Gmbh | Use of a beta-3 agonist for treating complaints of the prostate and the lower urogenital tract |
WO2006045519A1 (en) | 2004-10-26 | 2006-05-04 | Kissei Pharmaceutical Co., Ltd. | Synthesis of phenoxyacetic acid derivatives |
TWI356699B (en) * | 2004-11-10 | 2012-01-21 | Kissei Pharmaceutical | Agent for treating interstitial cystitis and agent |
JPWO2006123517A1 (ja) * | 2005-04-26 | 2008-12-25 | キッセイ薬品工業株式会社 | ヒドロキシノルエフェドリン誘導体塩酸塩の結晶多形 |
CA2605298A1 (en) * | 2005-04-26 | 2006-11-09 | Kissei Pharmaceutical Co., Ltd. | Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate |
EP1769792A1 (de) | 2005-09-30 | 2007-04-04 | Boehringer Ingelheim Pharma GmbH & Co.KG | Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden |
CA2988753A1 (en) | 2007-08-06 | 2009-02-12 | Serenity Pharmaceuticals, Llc | Methods and devices for desmopressin drug delivery |
LT2712622T (lt) | 2008-05-21 | 2016-09-26 | Ferring B.V. | Burnoje disperguojamas desmopresinas, skirtas nikturijos netrikdomo miego pirminio periodo pailginimui |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY126489A (en) * | 1998-07-08 | 2006-10-31 | Kissei Pharmaceutical | Phenoxyacetic acid derivatives and medicinal compositions containing the same |
JP4005729B2 (ja) * | 1999-01-21 | 2007-11-14 | キッセイ薬品工業株式会社 | アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形 |
JP4005730B2 (ja) * | 1999-01-21 | 2007-11-14 | キッセイ薬品工業株式会社 | アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形 |
JP4005731B2 (ja) * | 1999-01-21 | 2007-11-14 | キッセイ薬品工業株式会社 | アミノエチルフェノキシ酢酸誘導体の結晶多形 |
-
2002
- 2002-08-27 JP JP2003528764A patent/JP4157036B2/ja not_active Expired - Fee Related
- 2002-08-27 MX MXPA04002449A patent/MXPA04002449A/es active IP Right Grant
- 2002-08-27 PT PT02765352T patent/PT1426355E/pt unknown
- 2002-08-27 IL IL16068102A patent/IL160681A0/xx unknown
- 2002-08-27 CN CNB028175964A patent/CN1275936C/zh not_active Expired - Fee Related
- 2002-08-27 KR KR1020047003545A patent/KR100874952B1/ko not_active IP Right Cessation
- 2002-08-27 CA CA2458544A patent/CA2458544C/en not_active Expired - Fee Related
- 2002-08-27 AU AU2002330453A patent/AU2002330453B2/en not_active Ceased
- 2002-08-27 AT AT02765352T patent/ATE411276T1/de active
- 2002-08-27 US US10/489,343 patent/US7208520B2/en not_active Expired - Fee Related
- 2002-08-27 EP EP02765352A patent/EP1426355B1/en not_active Expired - Lifetime
- 2002-08-27 WO PCT/JP2002/008596 patent/WO2003024916A1/ja active IP Right Grant
- 2002-08-27 SI SI200230775T patent/SI1426355T1/sl unknown
- 2002-08-27 ES ES02765352T patent/ES2314092T3/es not_active Expired - Lifetime
- 2002-08-27 KR KR1020087026126A patent/KR20080098691A/ko not_active Application Discontinuation
- 2002-08-27 UA UA2004031852A patent/UA77000C2/uk unknown
- 2002-08-27 PL PL367874A patent/PL206246B1/pl not_active IP Right Cessation
- 2002-08-27 EA EA200400311A patent/EA006022B1/ru not_active IP Right Cessation
- 2002-08-27 DE DE60229404T patent/DE60229404D1/de not_active Expired - Lifetime
- 2002-08-27 DK DK02765352T patent/DK1426355T3/da active
- 2002-08-27 BR BR0212494-7A patent/BR0212494A/pt not_active IP Right Cessation
- 2002-08-27 HU HU0401694A patent/HUP0401694A3/hu unknown
-
2003
- 2003-08-27 NZ NZ531602A patent/NZ531602A/en not_active IP Right Cessation
-
2004
- 2004-03-02 IL IL160681A patent/IL160681A/en not_active IP Right Cessation
- 2004-03-03 ZA ZA200401757A patent/ZA200401757B/en unknown
- 2004-03-12 CO CO04022925A patent/CO5560555A2/es not_active Application Discontinuation
- 2004-03-12 HR HR20040250A patent/HRP20040250A2/hr not_active Application Discontinuation
- 2004-03-12 NO NO20041060A patent/NO328252B1/no not_active IP Right Cessation
- 2004-03-12 EC EC2004005017A patent/ECSP045017A/es unknown
-
2005
- 2005-04-04 HK HK05102803A patent/HK1070051A1/xx not_active IP Right Cessation
-
2009
- 2009-01-14 CY CY20091100027T patent/CY1109409T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200400311A1 (ru) | Кристаллы производных гидроксинорэфедрина | |
RU2445312C2 (ru) | ПРОИЗВОДНЫЕ 2-МЕТИЛМОРФОЛИН ПИРИДО-, ПИРАЗО- И ПИРИМИДО-ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ mTOR | |
EA200702498A1 (ru) | N-(пиридин-2-ил)сульфонамидные производные | |
BRPI0409227B8 (pt) | "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)" | |
EA200201271A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
BR0212378A (pt) | Inibidores de 17beta-hidroxiesteróide desidrogenase tipo 3 para o tratamento de doenças dependentes de androgênio | |
BRPI0418245B8 (pt) | composto derivado de nitróxi de prostaglandina, processo para preparar dito composto, composição farmacêutica compreendendo dito composto e usos destes | |
RU96109378A (ru) | Ингибиторы протеазы вич | |
BR0111913A (pt) | Análogos de gabapentina para distúrbios do sono | |
BR0315580A (pt) | Derivados de metileno uréia | |
WO2005097122A3 (en) | Method of treating schizophrenia and/or glucoregulatory abnormalities | |
RU97117350A (ru) | Ингибитор гипертрофии интимы, применение оксиндолового производного для получения ингибитора гипертрофии интимы, композиция для ингибирования гипертрофии интимы, способ предупреждения и лечения гипертрофии интимы | |
DE602005017162D1 (de) | 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i | |
PT1336407E (pt) | Composicao contendo um antagonista do receptor de angiotensina e um diuretico e sua utilizacao para o tratamento da hipertensao | |
SE9903894D0 (sv) | Novel compounds | |
AR038658A1 (es) | Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento | |
DE60014343D1 (de) | N-(2-phenyl-4-amino-butyl)-1-naphthamide als neurokinin-1 rezeptorantagonisten | |
EA200600866A1 (ru) | Применение галоидного производного гидроксимовой кислоты для лечения нейродегенеративных заболеваний | |
EA200400707A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
BR0207886A (pt) | Ciclopropa-heterociclos como inibidores de transcriptase reversa não-nucleosìdeos | |
SE9900190D0 (sv) | New compounds | |
EA200600022A1 (ru) | Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций | |
EP1431294A4 (en) | ACAT INHIBITOR WITH SELECTIVITY FOR VESSEL WALLS | |
EA200400709A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
DK1224161T3 (da) | Nitroxyderivater af (R)- og (S)-carnitin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |